增加氧气消耗能力与肺部康复改善了高级COPD的亚最大运动能力
Hitoshi Sumitani1,2, Keisuke Miki2, Yukio Yamamoto3
1Dr. Sumitani is affiliated with Department of Respiratory Medicine, NHO Kinki-Chuo Chest Medical Center, Sakai, Japan.
Respiratory care
|March 11, 2025
概括
在高峰运动时,改善吸入和呼出空气 (ΔFO2) 之间的氧气度差异,而不是每分钟的通风 (V ̇E),对于在进行肺康复的高级COPD患者中提高无氧值 (AT) 是关键.
科学领域:
- 肺部医学 肺部医学
- 运动生理学 运动生理学
- 心肺康复中心心肺康复中心
背景情况:
- 改善无氧值 (AT) 对于治疗COPD至关重要,但影响AT改善的因素尚不清楚.
- 肺部康复 (PR) 旨在改善COPD患者的运动能力.
- 识别AT增强的关键变量可以优化公关策略.
研究的目的:
- 在重度至非常重度的COPD患者中,在肺部康复 (PR) 后,与改善的无氧值 (AT) 相关的变量.
- 为了比较COPD患者的运动反应,这些患者增加了他们的AT和那些在PR后没有.
- 为了确定氧度变化 (ΔFO2) 和每分钟通风 (V ̇E) 与AT改善之间的关系.
主要方法:
- 稳定的COPD患者 (严重/非常严重) 接受了为期4周的PR.
- 心肺运动测试 (CPET) 评估了PR之前和之后的AT.
- 为了进行比较分析,患者根据PR后的AT增加进行了分组.
主要成果:
- 增加AT的小组在运动高峰时显示出氧气吸收峰值 (V ̇O2) 和 ΔFO2 的显著改善,与没有增加AT的小组不同.
- 在PR后的AT中增加的V ̇O2与峰值运动时增强的DFO2有很强的相关性.
- 在峰值炼时的 ΔFO2 被确定为AT改善的主要相关因子,独立于 V ̇E.
结论:
- 在峰值炼时增强的 ΔFO2,而不是 V ̇E,与在PR后的晚期COPD患者中改善的AT显著相关.
- 针对 ΔFO2 的改善可能为个性化肺部康复提供一个战略.
- 这一发现表明,在运动期间优化氧气利用是COPD中AT增长的关键.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
COPD: Pathogenesis and Clinical Features
223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223


